EDGAR Filing Documents for 0001104659-24-049972

Form SC 13G - Statement of Beneficial Ownership by Certain Investors:

SEC Accession No. 0001104659-24-049972

Filing Date

2024-04-22

Accepted

2024-04-22 16:05:53

Documents

Group Members

CITADEL ADVISORS HOLDINGS LPCITADEL GP LLCCITADEL SECURITIES GP LLCCITADEL SECURITIES GROUP LPCITADEL SECURITIES LLCKENNETH GRIFFIN

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13G	tm2412383d1_sc13g.htm	SC 13G	120119
2	EXHIBIT 99.1	tm2412383d1_ex99-1.htm	EX-99.1	8512
	Complete submission text file	0001104659-24-049972.txt		130709

Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010

Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337

Protara Therapeutics, Inc. (Subject) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88372 | Film No.: 24861217
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address SOUTHEAST FINANCIAL CENTER 200 S. BISCAYNE BLVD., SUITE 3300 MIAMI FL 33131

Business Address SOUTHEAST FINANCIAL CENTER 200 S. BISCAYNE BLVD., SUITE 3300 MIAMI FL 33131 305-929-6851

CITADEL ADVISORS LLC (Filed by) CIK: 0001423053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G